LSX - The Network For Life Science Executives

200+ life science investors you need to meet

Meet 200+ investor and strategics that have active mandates in investing and supporting life science and healthcare companies, from drug discovery / design to on-the-market, and everything in between.

For the purpose of this report we’ve aggregated and summarised the investment preferences of these firms and highlighted which therapeutic and technology areas are attracting the most attention right now.

Their contributions to the ongoing development of biotech, healthtech, medtech and deeptech companies in this region cannot be overlooked and, if you are not already connected with these firms, they should be on your radar.

These 200+ firms make up the present cohort of investor and strategic attendees to the 8th LSX World Congress taking place in-person across the 8-9 February, in London. Over 1000 delegates are expected.

Download the pdf report
https://bit.ly/306htjv